Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Subtherapeutic doses of SSRI antidepressants demonstrate considerable serotonin transporter occupancy: implications for tapering SSRIs.

× No keyword cloud information.

14 in total

Review 1. Tablet splitting: a review of weight and content uniformity.

Authors: Maisha Kelly Freeman; Whitney White; Maryam Iranikhah
Journal: Consult Pharm Date: 2012-05

Review 2. Antidepressant discontinuation syndrome.

Authors: Christopher H Warner; William Bobo; Carolynn Warner; Sara Reid; James Rachal
Journal: Am Fam Physician Date: 2006-08-01 Impact factor: 3.292

3. Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms.

Authors: Aytekin Sir; Russell F D'Souza; Sukru Uguz; Tom George; Simavi Vahip; Malcolm Hopwood; Andrew J Martin; William Lam; Tal Burt
Journal: J Clin Psychiatry Date: 2005-10 Impact factor: 4.384

4. Medication withdrawal symptoms in obsessive-compulsive disorder patients treated with paroxetine.

Authors: N J Keuthen; P Cyr; J A Ricciardi; W E Minichiello; M L Buttolph; M A Jenike
Journal: J Clin Psychopharmacol Date: 1994-06 Impact factor: 3.153

5. Time-course of serotonin transporter occupancy by single dose of three SSRIs in human brain: A positron emission tomography study with [(11)C]DASB.

Authors: Ryosuke Arakawa; Amane Tateno; WooChan Kim; Takeshi Sakayori; Kohei Ogawa; Yoshiro Okubo
Journal: Psychiatry Res Neuroimaging Date: 2016-03-28 Impact factor: 2.376

6. Similar discontinuation symptoms for withdrawal from medium-dose paroxetine and venlafaxine after nine years in the same patient.

Authors: G D Kotzalidis; E de Pisa; B Patrizi; V Savoja; G Ruberto; P Girardi
Journal: J Psychopharmacol Date: 2008-01-21 Impact factor: 4.153

7. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.

Authors: J F Rosenbaum; M Fava; S L Hoog; R C Ascroft; W B Krebs
Journal: Biol Psychiatry Date: 1998-07-15 Impact factor: 13.382

8. The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study.

Authors: Aung Tint; Peter M Haddad; Ian M Anderson
Journal: J Psychopharmacol Date: 2008-05 Impact factor: 4.153

9. Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.

Authors: Jeffrey H Meyer; Alan A Wilson; Sandra Sagrati; Doug Hussey; Anna Carella; William Z Potter; Nathalie Ginovart; Edgar P Spencer; Andy Cheok; Sylvain Houle
Journal: Am J Psychiatry Date: 2004-05 Impact factor: 18.112

10. Effects of the serotonin 1A, 2A, 2C, 3A, and 3B and serotonin transporter gene polymorphisms on the occurrence of paroxetine discontinuation syndrome.

Authors: Yusuke Murata; Daisuke Kobayashi; Nanae Imuta; Koichi Haraguchi; Ichiro Ieiri; Ryoji Nishimura; Susumu Koyama; Kazunori Mine
Journal: J Clin Psychopharmacol Date: 2010-02 Impact factor: 3.153

1 in total

1. Designing Flexible Longitudinal Regimens: Supporting Clinician Planning for Discontinuation of Psychiatric Drugs.

Authors: Eunkyung Jo; Myeonghan Ryu; Georgia Kenderova; Samuel So; Bryan Shapiro; Alexandra Papoutsaki; Daniel A Epstein
Journal: Proc SIGCHI Conf Hum Factor Comput Syst Date: 2022-04-29

1 in total